Annual Operating Profit
-$39.06 M
+$18.51 M+32.15%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual operating income is -$39.06 million, with the most recent change of +$18.51 million (+32.15%) on December 31, 2023.
- During the last 3 years, UBX annual operating profit has risen by +$52.27 million (+57.23%).
- UBX annual operating profit is now -107.31% below its all-time high of -$18.84 million, reached on December 31, 2016.
Performance
UBX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$6.60 M
+$377.00 K+5.40%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly operating income is -$6.60 million, with the most recent change of +$377.00 thousand (+5.40%) on September 30, 2024.
- Over the past year, UBX quarterly operating profit has increased by +$2.38 million (+26.47%).
- UBX quarterly operating profit is now at all-time high.
Performance
UBX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$28.86 M
+$2.38 M+7.61%
September 30, 2024
Summary
- As of February 8, 2025, UBX TTM operating income is -$28.86 million, with the most recent change of +$2.38 million (+7.61%) on September 30, 2024.
- Over the past year, UBX TTM operating profit has increased by +$16.45 million (+36.30%).
- UBX TTM operating profit is now -219.21% below its all-time high of -$9.04 million, reached on March 31, 2017.
Performance
UBX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
UBX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.1% | +26.5% | +36.3% |
| 3 y3 years | +57.2% | +52.6% | +49.9% |
| 5 y5 years | +47.9% | +52.6% | +49.9% |
UBX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.1% | at high | +63.9% | at high | +51.9% |
| 5 y | 5-year | at high | +57.2% | at high | +74.0% | at high | +70.0% |
| alltime | all time | -107.3% | +57.2% | at high | +74.0% | -219.2% | +70.0% |
Unity Biotechnology Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.60 M(-5.4%) | -$28.86 M(-7.6%) |
| Jun 2024 | - | -$6.98 M(-8.2%) | -$31.23 M(-13.5%) |
| Mar 2024 | - | -$7.60 M(-1.0%) | -$36.10 M(-7.6%) |
| Dec 2023 | -$39.06 M(-32.1%) | -$7.68 M(-14.5%) | -$39.06 M(-13.8%) |
| Sep 2023 | - | -$8.98 M(-24.2%) | -$45.30 M(-8.4%) |
| Jun 2023 | - | -$11.85 M(+12.2%) | -$49.45 M(-0.8%) |
| Mar 2023 | - | -$10.56 M(-24.1%) | -$49.86 M(-13.4%) |
| Dec 2022 | -$57.57 M(+1.6%) | -$13.92 M(+6.0%) | -$57.57 M(+7.5%) |
| Sep 2022 | - | -$13.13 M(+7.1%) | -$53.55 M(-3.1%) |
| Jun 2022 | - | -$12.26 M(-32.9%) | -$55.25 M(-7.9%) |
| Mar 2022 | - | -$18.27 M(+84.6%) | -$59.99 M(+5.9%) |
| Dec 2021 | -$56.66 M(-38.0%) | -$9.90 M(-33.2%) | -$56.66 M(-12.9%) |
| Sep 2021 | - | -$14.83 M(-12.8%) | -$65.08 M(-13.9%) |
| Jun 2021 | - | -$17.00 M(+13.7%) | -$75.61 M(-6.7%) |
| Mar 2021 | - | -$14.94 M(-18.4%) | -$81.06 M(-11.2%) |
| Dec 2020 | -$91.33 M | -$18.31 M(-27.8%) | -$91.33 M(-5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$25.36 M(+13.0%) | -$96.14 M(+2.0%) |
| Jun 2020 | - | -$22.44 M(-11.0%) | -$94.24 M(-1.0%) |
| Mar 2020 | - | -$25.22 M(+9.1%) | -$95.24 M(+4.7%) |
| Dec 2019 | -$91.00 M(+21.5%) | -$23.11 M(-1.5%) | -$91.00 M(+2.8%) |
| Sep 2019 | - | -$23.47 M(+0.1%) | -$88.55 M(+5.6%) |
| Jun 2019 | - | -$23.44 M(+11.7%) | -$83.82 M(+5.5%) |
| Mar 2019 | - | -$20.98 M(+1.6%) | -$79.42 M(+6.0%) |
| Dec 2018 | -$74.92 M(+64.3%) | -$20.66 M(+10.2%) | -$74.92 M(+11.7%) |
| Sep 2018 | - | -$18.74 M(-1.6%) | -$67.05 M(+11.0%) |
| Jun 2018 | - | -$19.04 M(+15.5%) | -$60.39 M(+13.8%) |
| Mar 2018 | - | -$16.48 M(+28.9%) | -$53.05 M(+16.3%) |
| Dec 2017 | -$45.61 M(+142.0%) | -$12.79 M(+5.8%) | -$45.61 M(+39.0%) |
| Sep 2017 | - | -$12.08 M(+3.3%) | -$32.82 M(+58.3%) |
| Jun 2017 | - | -$11.70 M(+29.4%) | -$20.74 M(+129.4%) |
| Mar 2017 | - | -$9.04 M | -$9.04 M |
| Dec 2016 | -$18.84 M | - | - |
FAQ
- What is Unity Biotechnology annual operating income?
- What is the all time high annual operating profit for Unity Biotechnology?
- What is Unity Biotechnology annual operating profit year-on-year change?
- What is Unity Biotechnology quarterly operating income?
- What is the all time high quarterly operating profit for Unity Biotechnology?
- What is Unity Biotechnology quarterly operating profit year-on-year change?
- What is Unity Biotechnology TTM operating income?
- What is the all time high TTM operating profit for Unity Biotechnology?
- What is Unity Biotechnology TTM operating profit year-on-year change?
What is Unity Biotechnology annual operating income?
The current annual operating profit of UBX is -$39.06 M
What is the all time high annual operating profit for Unity Biotechnology?
Unity Biotechnology all-time high annual operating income is -$18.84 M
What is Unity Biotechnology annual operating profit year-on-year change?
Over the past year, UBX annual operating income has changed by +$18.51 M (+32.15%)
What is Unity Biotechnology quarterly operating income?
The current quarterly operating profit of UBX is -$6.60 M
What is the all time high quarterly operating profit for Unity Biotechnology?
Unity Biotechnology all-time high quarterly operating income is -$6.60 M
What is Unity Biotechnology quarterly operating profit year-on-year change?
Over the past year, UBX quarterly operating income has changed by +$2.38 M (+26.47%)
What is Unity Biotechnology TTM operating income?
The current TTM operating profit of UBX is -$28.86 M
What is the all time high TTM operating profit for Unity Biotechnology?
Unity Biotechnology all-time high TTM operating income is -$9.04 M
What is Unity Biotechnology TTM operating profit year-on-year change?
Over the past year, UBX TTM operating income has changed by +$16.45 M (+36.30%)